Helping patients quit smoking during lung cancer screening
Providing Tobacco Treatment to Patients Undergoing Lung Cancer Screening at MedStar Health: A Randomized Trial
This study is looking at how well smoking cessation support works for people getting screened for lung cancer, especially for those from diverse backgrounds, to help them quit smoking more easily.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Georgetown University NIH-funded |
| Lab location | 1 site (Washington, United States) |
| Project ID | NIH-11070301 on NIH RePORTER |
What this research studies
This research investigates the effectiveness of providing smoking cessation treatments to patients who are undergoing lung cancer screening. It aims to address barriers that prevent patients, especially those from diverse and underserved backgrounds, from receiving these treatments. By conducting a randomized trial at multiple lung screening sites within the MedStar Health system, the study will compare two evidence-based cessation methods and implement strategies to enhance patient engagement. The goal is to improve the integration of cessation support into routine lung cancer screening practices.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who are scheduled for lung cancer screening and currently smoke.
Not a fit: Patients who do not smoke or are not undergoing lung cancer screening may not receive any benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce lung cancer deaths and improve the quality of life for patients by increasing smoking cessation rates.
How similar studies have performed: Previous research has shown that integrating smoking cessation support into cancer screening programs can lead to improved patient outcomes, indicating a promising approach.
Where this research is happening
Washington, United States
- Georgetown University — Washington, United States (Active)
Researchers
- Principal investigator: Taylor, Kathryn L — Georgetown University
- Study coordinator: Taylor, Kathryn L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.